Harbin Pharmaceutical Group Co Ltd banner

Harbin Pharmaceutical Group Co Ltd
SSE:600664

Watchlist Manager
Harbin Pharmaceutical Group Co Ltd Logo
Harbin Pharmaceutical Group Co Ltd
SSE:600664
Watchlist
Price: 3.49 CNY 0.87%
Market Cap: ¥8.8B

Profitability Summary

Harbin Pharmaceutical Group Co Ltd's profitability score is 48/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score
48/100
Profitability
Score

Margins

Earnings Waterfall
Harbin Pharmaceutical Group Co Ltd

Margins Comparison
Harbin Pharmaceutical Group Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Harbin Pharmaceutical Group Co Ltd
SSE:600664
8.8B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
932.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
271B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
224.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
287.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.8B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
121B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Harbin Pharmaceutical Group Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Harbin Pharmaceutical Group Co Ltd
SSE:600664
8.8B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
932.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
271B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
224.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
287.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.8B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
121B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Harbin Pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett